Translumina Acquires Lamed GmbH

June 12, 2023—Translumina, an interventional cardiovascular medical devices company with manufacturing presence in Germany and India, announced the acquisition of Munich, Germany-based Lamed GmbH.

According to Translumina, Lamed has a market-access platform of vascular and cardiovascular products that covers more than 1,000 hospitals through its group purchasing organization (GPO) network in Germany. The company exclusively distributes a portfolio of differentiated products for an international supplier base. Lamed was established in 1989.

Translumina stated it intends to leverage Lamed’s platform to introduce a basket of owned and partnered products in the German market.

Gurmit Singh Chugh, who cofounded Translumina with Punita Sharma in 2010, commented in the company’s press release, “This acquisition is of strategic importance and gives us significant access in vascular and cardiovascular markets in Germany, which is one of the largest in Europe. The synergy of our unique technologies and market penetration of Lamed shall create a formidable business opportunity for us.”

Lazaros Ayvatoglou, the founder of Lamed, commented in the press release, “After the initial discussion, it was clear that both businesses enrich each other with manifold growth opportunities. I am happy to have found a partner that builds on the established foundation of Lamed for a successful future.”

Arjun Oberoi, Managing Director at Singapore-based private equity firm Everstone Capital, added in the press release, “Translumina’s acquisition of Lamed positions us for accelerated growth in Germany’s thriving peripheral interventional and vascular surgery sector. With access to major GPOs and hospitals in the largest European medical devices market, we are poised to excel in interventional cardiology, peripheral vascular, and structural heart disease segments.”